Not applicableStudy completedNCT01637233What this trial is testingMARCH Central Nervous System SubstudyWho this might be right forHIV-1 Infection Kirby Institute 28
Post-approval studies (Phase 4)Study completedNCT00389194What this trial is testingPREventing Progression of Adipose Tissue RedistributionWho this might be right forHIV Infections International Antiviral Therapy Evaluation Center 120
Post-approval studies (Phase 4)Study completedNCT00287677What this trial is testingInduction and Expansion of T Cell Repertoire Using Growth Hormone and Vaccination in HIV-1 Infected PatientsWho this might be right forHIV Infections Germans Trias i Pujol Hospital 33
Not applicableStudy completedNCT04133012What this trial is testingCartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors BackboneWho this might be right forHIV-1 Infection ANRS, Emerging Infectious Diseases 20
Not applicableEnded earlyNCT01567722What this trial is testingCollecting and Studying Tissue Samples From Patients With HIV-Associated MalignanciesWho this might be right forLung CancerLymphoma AIDS Malignancy Consortium 114
Large-scale testing (Phase 3)Study completedNCT03913195What this trial is testingStudy of the Safety of Trogarzo™ Administered as an Undiluted "IV Push" or an Intramuscular InjectionWho this might be right forHIV-1-infection TaiMed Biologics Inc. 43
Large-scale testing (Phase 3)Study completedNCT02006745What this trial is testingOpen Label Trial of PEG-IFN, RBV & TVR vs. PEG-IFN & RBV Alone in Tx of HCV-1 in HIV-1 Co-infected Patients (CHAT)Who this might be right forHIV St Stephens Aids Trust 20
Not applicableStudy completedNCT00734344What this trial is testingPilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 InfectionWho this might be right forAcute HIV Infection University of Alabama at Birmingham 18
Early research (Phase 1)Study completedNCT05197075What this trial is testingAssess the Acceptability of the Darunavir/Cobicistat (DRV/COBI) Fixed-dose Combination (FDC) Tablet in Human Immunodeficiency Virus (HIV)-1 Infected ChildrenWho this might be right forHuman Immunodeficiency Virus (HIV) Janssen Research & Development, LLC 15
Not applicableWithdrawnNCT00165919What this trial is testingImmune Response to Hepatitis C VirusWho this might be right forHepatitis CHIV Infections Emory University
Large-scale testing (Phase 3)Study completedNCT00480792What this trial is testingTrial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected PatientsWho this might be right forHIV Infections ANRS, Emerging Infectious Diseases 437
Not applicableStudy completedNCT00002404What this trial is testingThe Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions in HIV-Infected PatientsWho this might be right forHerpes SimplexHIV Infections Glaxo Wellcome 30
Post-approval studies (Phase 4)Study completedNCT04388904What this trial is testingRapid Reinitiation of a Single Tablet Antiretroviral Therapy Using Symtuza® in HIV-1 Infected Treatment-Experienced Patients Off Therapy. (ReSTART)Who this might be right forHIV-1-infection The Crofoot Research Center, Inc. 75
Not applicableStudy completedNCT00005278What this trial is testingRetrovirus Epidemiology Donor Study I (REDS I)Who this might be right forAcquired Immunodeficiency SyndromeBlood DonorsBlood Transfusion+6 more National Heart, Lung, and Blood Institute (NHLBI)
Early research (Phase 1)Looking for participantsNCT03729752What this trial is testingPET Imaging of Radiolabeled Anti-HIV-1 Envelope Monoclonal Antibody (VRC01)Who this might be right forHIV-1-infection University of California, San Francisco 30
Testing effectiveness (Phase 2)UnknownNCT00622232What this trial is testingA Rollover Study for Subjects Who Completed Participation in the VRX496-USA-05-002 TrialWho this might be right forHIV Infections VIRxSYS Corporation 40
Early research (Phase 1)Study completedNCT00001021What this trial is testingA Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine Given Either Alone or in Combination With IIIB rgp120/HIV-1 Vaccine in Healthy Adult Subjects (NOTE: Original Study Extended ONLY for Patients Previously Enrolled on VEU 009)Who this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 57
Large-scale testing (Phase 3)Active Not RecruitingNCT05631093What this trial is testingA Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Antiretroviral Therapy (ART) (MK-8591A-051)Who this might be right forHIV-1 Infection Merck Sharp & Dohme LLC 553
Early research (Phase 1)Study completedNCT00119873What this trial is testingSafety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected AdultsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT00001031What this trial is testingA Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy AdultsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 296